Bank of America’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6
| Closed | -$165 | – | 6335 |
|
|
2025
Q4 | $165 | Sell |
6
-24
| -80% | -$1.07K | ﹤0.01% | 6735 |
|
|
2025
Q3 | $2.33K | Buy |
30
+28
| +1,400% | +$13.9K | ﹤0.01% | 7387 |
|
|
2025
Q2 | $466 | Buy |
2
+1
| +100% | +$195 | ﹤0.01% | 7680 |
|
|
2025
Q1 | $281 | Hold |
1
| – | – | ﹤0.01% | 7623 |
|
|
2024
Q4 | $257 | Hold |
1
| – | – | ﹤0.01% | 7536 |
|
|
2024
Q3 | $188 | Buy |
+1
| New | +$315 | ﹤0.01% | 7583 |
|
|
2024
Q2 | – | Sell |
-2
| Closed | -$661 | – | 7636 |
|
|
2024
Q1 | $885 | Sell |
2
-50
| -96% | -$18.6K | ﹤0.01% | 7217 |
|
|
2023
Q4 | $18.1K | Buy |
52
+50
| +2,500% | +$17.7K | ﹤0.01% | 6805 |
|
|
2023
Q3 | $1.02K | Sell |
2
-162
| -99% | -$106K | ﹤0.01% | 7233 |
|
|
2023
Q2 | $120K | Buy |
164
+57
| +53% | +$44.2K | ﹤0.01% | 6126 |
|
|
2023
Q1 | $80.5K | Sell |
107
-159
| -60% | -$139K | ﹤0.01% | 6333 |
|
|
2022
Q4 | $507K | Buy |
266
+264
| +13,200% | +$105K | ﹤0.01% | 5366 |
|
|
2022
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 7675 |
|
|
2022
Q2 | $1K | Sell |
2
-190
| -99% | -$298K | ﹤0.01% | 7870 |
|
|
2022
Q1 | $662K | Sell |
192
-12
| -6% | -$31.4K | ﹤0.01% | 5613 |
|
|
2021
Q4 | $618K | Buy |
204
+188
| +1,175% | +$872K | ﹤0.01% | 5682 |
|
|
2021
Q3 | $104K | Sell |
16
-28
| -64% | -$242K | ﹤0.01% | 6703 |
|
|
2021
Q2 | $577K | Buy |
44
+1
| +2% | +$15.7K | ﹤0.01% | 5306 |
|
|
2021
Q1 | $719K | Sell |
43
-153
| -78% | -$2.99M | ﹤0.01% | 5093 |
|
|
2020
Q4 | $3.33M | Sell |
196
-10
| -5% | -$188K | ﹤0.01% | 3505 |
|
|
2020
Q3 | $3.87M | Buy |
206
+48
| +30% | +$1.1M | ﹤0.01% | 3143 |
|
|
2020
Q2 | $4.16M | Buy |
158
+2
| +1% | +$56.7K | ﹤0.01% | 3000 |
|
|
2020
Q1 | $3.42M | Buy |
156
+128
| +457% | +$2.05M | ﹤0.01% | 3038 |
|
|
2019
Q4 | $262K | Sell |
28
-4
| -13% | -$38.6K | ﹤0.01% | 5454 |
|
|
2019
Q3 | $302K | Sell |
32
-3
| -9% | -$36.5K | ﹤0.01% | 5409 |
|
|
2019
Q2 | $561K | Sell |
35
-150
| -81% | -$2.48M | ﹤0.01% | 4980 |
|
|
2019
Q1 | $3.81M | Buy |
185
+166
| +874% | +$2.95M | ﹤0.01% | 3418 |
|
|
2018
Q4 | $236K | Sell |
19
-13
| -41% | -$225K | ﹤0.01% | 5416 |
|
|
2018
Q3 | $781K | Buy |
32
+1
| +3% | +$30.5K | ﹤0.01% | 4645 |
|
|
2018
Q2 | $1.05M | Buy |
31
+2
| +7% | +$76.7K | ﹤0.01% | 4436 |
|
|
2018
Q1 | $1.15M | Buy |
29
+2
| +7% | +$75.9K | ﹤0.01% | 4296 |
|
|
2017
Q4 | $1.23M | Buy |
27
+24
| +800% | +$1.12M | ﹤0.01% | 4346 |
|
|
2017
Q3 | $144K | Buy |
+3
| New | +$165K | ﹤0.01% | 5528 |
|
Other funds holding KALA
VF
ACM
GCP
Bank of America's KALA Position: Q1 2026 in Review
Bank of America sold out of KALA BIO (KALA) in Q1 2026, closing a stake of 6 shares — an estimated $165 sold.
Bank of America first reported a position in KALA in Q3 2017 and held it in 33 quarters. The position peaked at $4.16M in Q2 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.
- Bank of America reported no remaining KALA BIO position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 6 KALA BIO shares in Q1 2026, an estimated $165.
- Bank of America first reported a position in KALA BIO in Q3 2017 and held it in 33 quarters.
- Bank of America's KALA BIO position peaked at $4.16M in Q2 2020.
- 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.